On January 23, 2024, Glycotest, Inc. closed the transaction. The company has raised $0.75 million in second and final tranche for aggregate gross proceeds of $1 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.5 GBX | -1.36% |
|
-0.68% | +20.83% |
06-13 | NetScientific loss narrows; assets under management top GBP100 million | AN |
06-13 | Earnings Flash (NSCI.L) NETSCIENTIFIC Posts FY23 Revenue GBP1.4M | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
72.5 GBX | -1.36% | -0.68% | 21.93M | ||
22.63 CNY | +2.49% | 0.00% | 7.57B | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.83% | 21.93M | |
+20.88% | 3.22B | |
+12.50% | 1.76B | |
+12.27% | 1.57B | |
-11.54% | 1.22B | |
+34.73% | 887M | |
+6.98% | 648M | |
+54.70% | 649M | |
-4.17% | 502M | |
+20.19% | 433M |
- Stock Market
- Equities
- NSCI Stock
- News NetScientific plc
- Glycotest, Inc. announced that it has received $1 million in funding from EMV Capital Ltd, NetScientific plc, Shanghai Fosun Pharmaceutical Co., Ltd.